Objective :
Competitors assessment of companies active in the pharma CDMO area
Problem Statement:
A CDMO client based in Europe, involved DelveInsight to provide in-depth competitor assessment of companies active in the pharma CDMO area, in order to understand effective landscaping and conduct strategic decision-making for gaining competitive advantage. The client wanted to expand their geographical scope and improve their product portfolio, for which they also requested competitive benchmarking outcomes from DelveInsight.
Our Methodology:
- Extensive secondary research
- List of CDMOs active in the European region
- Provided a robust competitive landscape
- Detailed profiling of the companies
- Service offerings
- Therapeutic area involvement
- Manufacturing capabilities and
- Details of market outreach
Results:
- A growing number of companies in drug development has led to a large surge of CDMO companies in the European and the USA region
- A growing number of companies in drug development has led to a large surge of CDMO companies in the European and the USA region
- Companies are developing antibodies and cell therapy candidates due to the vast research required .
- Protein manufacturing captures a large segment where companies are involved in contract development and manufacturing
- European Market outshines the no. of CMOs and CDMOs as well as the level of manufacturing output
- Competitive intelligence assessment pointed the top players in the market and their differentiating USPs